s Although C-reactive protein (CRP) has been shown to have a strong predictive value for future cardiovascular disease (CVD), it is still unclear whether CRP is a non-specific risk marker or a direct mediator in the pathogenesis of CVD. Despite the great clinical importance of CRP, we currently lack an appropriate animal model to study its role in CVD since mouse is not an appropriate animal model to study CRP functions. In this revised application, we have successfully generated both liver-specific (systemic) and vascular-specific (local) CRP transgenic rabbits because rabbits have a cardiovascular system and CRP response that are similar to those of humans. Intriguingly, our preliminary data have documented for the first time that increased systemic CRP can promote atherosclerosis in liver-specific CRP transgenic rabbits. Thus, the availability of these two unique CRP transgenic rabbit models would provide us powerful tools to define whether CRP participates in pathogenesis of CVD. In this proposal, we will test the central hypothesis that both liver-derived CRP and vascular-derived CRP act synergistically to produce the most extensive vascular lesion formation by activating vascular smooth muscle cell proliferation and migration in response to vascular injury. Specifically, we will 1). Define that CRP participates in pathogenesis of vascular disease using novel transgenic rabbit models, and 2). Define the relative influence of systemic CRP versus local CRP as a """"""""vasculopathic"""""""" mediator of vascular lesion formation in vivo. Overall, these studies will provide a definitive characterization of the mediator influence of CRP in CVD. Our studies will have profound implications on the understanding of CRP function in vascular disease and the full utility of CRP as a biomarker that guides clinical risk assessments and therapeutic strategies to prevent and treat CVD.
C-reactive protein (CRP) is an acute-phase reactant that exhibits increases in plasma levels during infection, systematic inflammation and tissue injury. Recently, epidemiological studies have demonstrated that circulating CRP levels are associated with an increased risk of cardiovascular disease (CVD) among apparently healthy individuals. Although CRP has been shown to have a strong predictive value for future CVD, it is still unclear whether CRP is a non- specific risk marker or a direct mediator in the pathogenesis of CVD. The studies proposed in this application will provide a definitive characterization of the mediator influence of CRP in CVD using CRP transgenic rabbit models. Our studies will have profound implications on the understanding of CRP biology in vascular diseases.
|Zhang, Ji; Qiao, Congzhen; Chang, Lin et al. (2016) Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy. PLoS One 11:e0157372|
|Guo, Yanhong; Fan, Yanbo; Zhang, Jifeng et al. (2015) Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production. J Clin Invest 125:3819-30|
|Fan, Jianglin; Kitajima, Shuji; Watanabe, Teruo et al. (2015) Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine. Pharmacol Ther 146:104-19|
|Yang, Dongshan; Xu, Jie; Zhu, Tianqing et al. (2014) Effective gene targeting in rabbits using RNA-guided Cas9 nucleases. J Mol Cell Biol 6:97-9|
|Brown, Nicholas K; Zhou, Zhou; Zhang, Jifeng et al. (2014) Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler Thromb Vasc Biol 34:1621-30|
|Yang, Dongshan; Zhang, Jifeng; Xu, Jie et al. (2013) Production of apolipoprotein C-III knockout rabbits using zinc finger nucleases. J Vis Exp :e50957|
|Wang, Yao; Niimi, Manabu; Nishijima, Kazutoshi et al. (2013) Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits. Arterioscler Thromb Vasc Biol 33:224-31|
|Zhang, Jifeng; Yu, Ying; Nakamura, Kae et al. (2012) Endothelial lipase mediates HDL levels in normal and hyperlipidemic rabbits. J Atheroscler Thromb 19:213-26|
|Chang, Lin; Villacorta, Luis; Li, Rongxia et al. (2012) Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-Ã½Ã½ deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 126:1067-78|
|Chen, Y Eugene; Xie, Changqing; Hamblin, Milton (2011) Smooth muscle cells for vascular engineering. Arterioscler Thromb Vasc Biol 31:2772-4|
Showing the most recent 10 out of 16 publications